menu
    • menu

    Company profile for Faron Pharmaceuticals

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Faron Pharmaceuticals Oy (AIM: FARN, First North: FARON), the clinical stage biopharmaceutical company, today announces that, due to the prevailing Covid-19 situation, the Company's Board of Directors has decided to cancel the Company's annual general meeting ("AGM") scheduled to be held on 15 April 2020.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Faron PharmaceuticalsFinland Flag
    Country
    Country
    Finland
    Address
    Address
    Joukahaisenkatu 6 FI-20520 TURKU
    Telephone
    Telephone
    +358 2 469 5151
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.faron.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Faron Pharma Ltd: Key Company Holdings
    Faron Pharma Ltd: Key Company Holdings

    04 Dec 2025

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2025-12-04/faron-pharmaceuticals-ltd-holding-s-in-company

    PHARMIWEB
    04 Dec 2025
    Share Share
    Faron Pharma Grants Stock Options
    Faron Pharma Grants Stock Options

    02 Dec 2025

    // ACCESSWIRE

    https://www.accessnewswire.com/newsroom/en/biotechnology/faron-pharmaceuticals-ltd-grant-of-options-1113685

    ACCESSWIRE
    02 Dec 2025
    Share Share
    Faron Pharmaceuticals Ltd: Appointment Of CFO
    Faron Pharmaceuticals Ltd: Appointment Of CFO

    01 Dec 2025

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2025-12-01/faron-pharmaceuticals-ltd-appointment-of-cfo

    PHARMIWEB
    01 Dec 2025
    Share Share
    Faron's 2026 Financial Calendar
    Faron's 2026 Financial Calendar

    27 Nov 2025

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2025-11-27/farons-financial-calendar-for-2026

    PHARMIWEB
    27 Nov 2025
    Share Share
    Faron to Issue Second €10M Convertible Bonds
    Faron to Issue Second €10M Convertible Bonds

    24 Nov 2025

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2025-11-24/inside-information-faron-intends-to-issue-second-tranche-of-bonds-with-an-aggregated-principal-amou

    PHARMIWEB
    24 Nov 2025
    Share Share
    Faron Reveals 2 Bexmarilimab Abstracts Accepted At ASH 2025
    Faron Reveals 2 Bexmarilimab Abstracts Accepted At ASH 2025

    04 Nov 2025

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2025-11-04/faron-announces-two-bexmarilimab-abstracts-accepted-at-ash-2025-including-an-oral-presentation-on-t

    PHARMIWEB
    04 Nov 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search